1. Home
  2. AMR vs AXSM Comparison

AMR vs AXSM Comparison

Compare AMR & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMR
  • AXSM
  • Stock Information
  • Founded
  • AMR 2016
  • AXSM 2012
  • Country
  • AMR United States
  • AXSM United States
  • Employees
  • AMR N/A
  • AXSM N/A
  • Industry
  • AMR Coal Mining
  • AXSM Biotechnology: Pharmaceutical Preparations
  • Sector
  • AMR Energy
  • AXSM Health Care
  • Exchange
  • AMR Nasdaq
  • AXSM Nasdaq
  • Market Cap
  • AMR 3.0B
  • AXSM 4.2B
  • IPO Year
  • AMR N/A
  • AXSM 2015
  • Fundamental
  • Price
  • AMR $192.50
  • AXSM $84.60
  • Analyst Decision
  • AMR Buy
  • AXSM Strong Buy
  • Analyst Count
  • AMR 2
  • AXSM 14
  • Target Price
  • AMR $336.00
  • AXSM $125.54
  • AVG Volume (30 Days)
  • AMR 202.7K
  • AXSM 893.5K
  • Earning Date
  • AMR 02-24-2025
  • AXSM 02-18-2025
  • Dividend Yield
  • AMR 1.04%
  • AXSM N/A
  • EPS Growth
  • AMR N/A
  • AXSM N/A
  • EPS
  • AMR 27.55
  • AXSM N/A
  • Revenue
  • AMR $3,299,929,000.00
  • AXSM $338,457,000.00
  • Revenue This Year
  • AMR N/A
  • AXSM $44.77
  • Revenue Next Year
  • AMR N/A
  • AXSM $67.70
  • P/E Ratio
  • AMR $6.99
  • AXSM N/A
  • Revenue Growth
  • AMR N/A
  • AXSM 51.47
  • 52 Week Low
  • AMR $173.55
  • AXSM $64.11
  • 52 Week High
  • AMR $452.00
  • AXSM $105.00
  • Technical
  • Relative Strength Index (RSI)
  • AMR 39.67
  • AXSM 43.66
  • Support Level
  • AMR $173.55
  • AXSM $79.19
  • Resistance Level
  • AMR $206.89
  • AXSM $87.53
  • Average True Range (ATR)
  • AMR 7.72
  • AXSM 4.37
  • MACD
  • AMR -0.21
  • AXSM -0.02
  • Stochastic Oscillator
  • AMR 56.84
  • AXSM 61.27

About AMR Alpha Metallurgical Resources Inc.

Alpha Metallurgical Resources Inc is a Tennessee-based coal mining company with operations across Virginia and West Virginia. The company's portfolio of mining operations consists of underground mines, surface mines and coal preparation plants. It produces low-ash metallurgical coal, including High-Vol. A, Mid-Vol., High-Vol. B, and Low-Vol. coal, which is shipped to domestic and international coke and steel producers. The reportable segments of the company are Met. It extracts, processes and markets met and thermal coal from deep and surface mines for sale to steel and coke producers, industrial customers, and electric utilities.

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

Share on Social Networks: